Genesis Innovation Group

Genesis is a technology driven firm, focused on the orthopedic space. Rather than focusing on a particular technology, Genesis is driven by the creation of value by identifying and understanding gaps in the orthopedic marketplace that provide opportunities where new technologies can improve the circumstances for all stakeholders in the care stream. With the belief that success depends on partnerships built on transparency and humility, Genesis is built on partnerships between accomplished and sucessful surgeons, commercial entities, and engineers. Genesis is more than an R&D consulting firm. It's strategy most commonly includes a deep engagement (and self financing) which drives partnerships toward shared objectives, creating an ideal win/win relationship.

Matt Ahearn

Director

Rob Ball

Director

Jeff Ondrla

Director

Don Running

Director

7 past transactions

HAPPE Spine

Venture Round in 2021
HAPPE Spine LLC is a healthcare company based in Grand Rapids, Michigan, that specializes in the development and commercialization of advanced material technology for spinal implants. Founded in 2018, the company focuses on creating partially or fully porous hydroxyapatite reinforced polyetheretherketone (PEEK) implants. These innovative implants are designed to offer optimal mechanical properties, enhanced surface texture for better bone engagement, and interconnected porosity that facilitates long-term fixation. Additionally, HAPPE Spine's technology incorporates bioactive properties, aiming to improve patient outcomes in spinal surgery. The company operates as a subsidiary of Genesis Innovation Group, LLC.

Virtual Incision

Series B in 2020
Virtual Incision is the pioneer of in vivo mini-robot surgery, enabling minimally-invasive colon resection and other abdominal procedures. Colorectal cancer is the second-deadliest form of the disease, and along with conditions like Diverticulitis and Crohn’s, treatment often requires a colectomy, almost 400,000 of which are performed each year in the U.S. alone. Two-thirds of these procedures are still performed open, requiring a long, gruesome incision. VIC’s simpler/easier/cheaper approach is to insert a mini-robot into the insufflated abdomen via a small umbilical incision, after which the highly-dextrous robot arms are freely manipulated at the nearby surgeon console. VIC enables MIS colectomy using well-known laparoscopic tools, onboard vision, and leading multi-quadrant capabilities. After 70+ pig labs and with 60+ patents/applications, VIC is seeking a $15M Series B financing to achieve First-in-Man and prepare for CE Mark and FDA 510(k) submissions.

Embody

Venture Round in 2019
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, established in 2014. The company specializes in the development and commercialization of implantable medical devices aimed at soft tissue restoration and regeneration. Embody focuses on creating innovative biomaterials for challenging orthopedic procedures, particularly in tendon and ligament repair, catering to the needs of warfighters, athletes, and the general public. Their product offerings include collagen-based microfiber implants designed for critical applications such as Achilles and rotator cuff repairs. Utilizing advanced technologies like microfluidic biofabrication and electrospinning, Embody aims to replicate the biological and biomechanical properties of native tissue, thereby enhancing the healing process and restoring pre-injury performance for patients suffering from sports-related injuries.

Shoulder Innovations

Series A in 2018
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, established in 2009. It specializes in designing and manufacturing orthopedic solutions specifically for shoulder replacement surgeries. The company's flagship product, the Total Shoulder Replacement System, features an innovative inset glenoid fixation technology, which enhances the stability and reliability of the glenoid implant—a critical factor in shoulder arthroplasty. This system aims to address the major challenge of implant fixation, which can lead to complications and the need for revision surgeries. Additionally, Shoulder Innovations provides the necessary surgical instrumentation that simplifies the implantation process, ultimately reducing operative time and costs. The company markets its products through distribution partners across the United States, focusing on improving patient outcomes and lowering overall healthcare expenses.

HAPPE Spine

Seed Round in 2018
HAPPE Spine LLC is a healthcare company based in Grand Rapids, Michigan, that specializes in the development and commercialization of advanced material technology for spinal implants. Founded in 2018, the company focuses on creating partially or fully porous hydroxyapatite reinforced polyetheretherketone (PEEK) implants. These innovative implants are designed to offer optimal mechanical properties, enhanced surface texture for better bone engagement, and interconnected porosity that facilitates long-term fixation. Additionally, HAPPE Spine's technology incorporates bioactive properties, aiming to improve patient outcomes in spinal surgery. The company operates as a subsidiary of Genesis Innovation Group, LLC.

Shoulder Innovations

Series A in 2017
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, established in 2009. It specializes in designing and manufacturing orthopedic solutions specifically for shoulder replacement surgeries. The company's flagship product, the Total Shoulder Replacement System, features an innovative inset glenoid fixation technology, which enhances the stability and reliability of the glenoid implant—a critical factor in shoulder arthroplasty. This system aims to address the major challenge of implant fixation, which can lead to complications and the need for revision surgeries. Additionally, Shoulder Innovations provides the necessary surgical instrumentation that simplifies the implantation process, ultimately reducing operative time and costs. The company markets its products through distribution partners across the United States, focusing on improving patient outcomes and lowering overall healthcare expenses.

Magnesium Development

Seed Round in 2016
Magnesium Development Company, LLC is a medical device developer based in Grand Rapids, Michigan, specializing in sports medicine orthopedics. Founded in 2014, the company focuses on innovative applications of its BioMg 250 magnesium alloy technology, which merges the strength and handling characteristics of traditional metals with the ability to fully absorb in the body. This technology addresses several challenges in surgical repairs, such as delayed resorption, mechanical failures, and complications related to existing materials. By providing solutions for soft tissue injuries in areas like the knee, shoulder, and lower extremities, Magnesium Development aims to enhance recovery outcomes and support patients' return to active lifestyles. As the demand for effective treatments in sports-related injuries continues to rise, the company’s breakthroughs in resorbable metal alloys position it as a key player in advancing orthopedic care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.